Emergent BioSolutions (EBS) Amortization of Deferred Charges (2017 - 2026)
Emergent BioSolutions (EBS) posted Amortization of Deferred Charges of $1.6 million for Q2 2026, down 11.11% on a QoQ basis from $1.8 million in Q1 2026, and down 33.33% year-over-year from $2.4 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Amortization of Deferred Charges (2017 - 2026) Analysis & Trends
Emergent BioSolutions has reported Amortization of Deferred Charges for 10 years, with the latest figure at $1.6 million in Q2 2026.
- On a quarterly basis, Amortization of Deferred Charges fell 33.33% year-over-year to $1.6 million in Q2 2026; TTM through Jun 2026 was $8.5 million, a 4150.0% increase from a year earlier, with the FY2025 full-year figure at $9.8 million, up 32.43% from the prior year.
- Amortization of Deferred Charges was $1.6 million for Q2 2026 at Emergent BioSolutions, down from $1.8 million in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $8.9 million in Q2 2023, with the low at -$6.7 million in Q3 2024.
- Average Amortization of Deferred Charges over 5 years is $2.6 million, with a median of $2.2 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Amortization of Deferred Charges soared 790.0% in 2023, then sank 217.54% in 2024.
- Over 5 years, Amortization of Deferred Charges stood at $1.0 million in 2022, then soared by 470.0% to $5.7 million in 2023, then plunged by 61.4% to $2.2 million in 2024, then rose by 18.18% to $2.6 million in 2025, then slumped by 38.46% to $1.6 million in 2026.
- The last three Amortization of Deferred Charges figures came in at $1.6 million (Q2 2026), $1.8 million (Q1 2026), and $2.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.60 Mn |
| Mar 31, 2026 | 1.80 Mn |
| Dec 31, 2025 | 2.60 Mn |
| Sep 30, 2025 | 2.50 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Mar 31, 2025 | 2.30 Mn |
| Dec 31, 2024 | 2.20 Mn |
| Sep 30, 2024 | -6.70 Mn |
| Jun 30, 2024 | 5.00 Mn |
| Mar 31, 2024 | 6.90 Mn |
| Dec 31, 2023 | 5.70 Mn |
| Sep 30, 2023 | 5.70 Mn |
| Jun 30, 2023 | 8.90 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 1.10 Mn |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 1.10 Mn |
API Access
Emergent BioSolutions Amortization of Deferred Charges API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "amortization-of-deferred-charges", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();